Phase 1 NASH trials recruiting now

All NASH trials, every phase

Other phases for NASH

Phase 1 NASH trials

• A Phase 1b Study of QX1206 in T2DM Patients With NAFLD
  NCT06694935 · Phase: Phase 1 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 1 location
• A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat
  NCT07214870 · Phase: Phase 1 · Ages: 18 Years to 69 Years · Sex: All (male and female) · 1 location
• A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects
  NCT07099118 · Phase: Phase 1 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
  NCT07358546 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 3 locations
• A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
  NCT05648214 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 6 locations
• Bicalutamide Therapy in Young Women With NAFLD and PCOS
  NCT05979389 · Phase: Phase 1 · Ages: 18 Years to 42 Years · Sex: Female · 2 locations
• COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study
  NCT06704516 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Female · 1 location
• Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease
  NCT07238985 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Dihydroartemisinin for MAFLD
  NCT07679542 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• Effect of Insulin Lowering on Lipogenesis
  NCT07403604 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease
  NCT07242222 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Evaluating the Pharmacokinetics and Safety of Miricorilant
  NCT07553663 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Human Models of Selective Insulin Resistance: Alpelisib, Part I
  NCT06354088 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Study of ECC4703 With Sulfasalazine and Pitavastatin
  NCT07726368 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects
  NCT06216041 · Phase: Phase 1 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAR502 in Healthy Subjects
  NCT06705998 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease（NAFLD）
  NCT07128797 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 5 locations

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.